Share of R&D costs for life sciences Japan FY 2013-2022
In the fiscal year 2022, about 16.3 percent of the total research and development expenditure for science and technology in Japan was utilized for life sciences. One of the most recognized life science innovations in Japan was "induced pluripotent stem cells" (iPS), which won the Nobel prize in physiology or medicine in 2012.